{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:45Z","timestamp":1753891305250,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The management of LT patients during COVID-19 pandemic is important. Immunosuppressants (IS) are key therapy agents after liver transplant. Different ISs have different side effects. Calcineurin inhibitor (CNI) may lead to metabolic acidosis while mycophenolate mofetil (MMF) showed rare nephrotoxicity. We report a post-liver transplant girl who was infected with SARS-CoV-2, developing a severe mixed acidosis 3 months after the transplantation. Her acidosis was improved after withdrawing of MMF, leading the suspicion that acidosis maybe a rare side effect of MMF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A girl was admitted to our hospital due to SARS-CoV-2 infection, 3 months before admission the patient received LT due to Niemann-Pick disease (NPD). During hospitalization, blood gas analysis showed severe mixed acidosis. To relieve mixed acidosis, the patient was given oral rehydration salt and liquid replacement therapy. Considering that immunosuppressants may cause metabolic acidosis, dose of CsA was decreased and MMF was discontinued.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>However, liquid replacement therapy and decreased CsA dose cannot improve the condition. As an attempt, MMF was discontinued, and 3 days later, the girl\u2019s acidosis was relieved, the latest blood gas analysis was normal with the original dose of CsA and no use of MMF or other IS. In addition, we used Naranjo Scale to see if adverse drug reactions (ADRs) existed. The final score was 6 which means MMF contributes to acidosis probably.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The girl\u2019s mixed acidosis cannot be explained by Niemann-Pick disease and SARS-CoV-2 infection. CNIs could cause metabolic acidosis but declining the dose of CsA didn\u2019t improve her acidosis while withdrawing MMF showed a good effect. Together with the Naranjo Scale result, we suspect that acidosis maybe a rare side effect of MMF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.972978","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:22:26Z","timestamp":1672863746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: One pediatric liver-transplant recipient with SARS-CoV-2 infection suffering unexplained mixed acidosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Lianhu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3748\/wjg.v26.i22.2987","article-title":"COVID-19 pandemic: its impact on liver disease and liver transplantation.","volume":"26","author":"Sahin","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.12998\/wjcc.v10.i15.4785","article-title":"Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: a case-control study.","volume":"10","author":"Akbulut","year":"2022","journal-title":"World J Clin Cases."},{"key":"B3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5152\/tjg.2022.21748","article-title":"Coronavirus precautions: experience of high volume liver transplant institute.","volume":"33","author":"Ba\u015fk\u0131ran","year":"2022","journal-title":"Turk J Gastroenterol."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2020.101681","article-title":"Immunosuppression in liver transplant.","author":"Di Maira","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.gastre.2020.10.001","article-title":"Liver transplant immunosuppression during the covid-19 pandemic.","volume":"43","author":"Forns","year":"2020","journal-title":"Gastroenterol Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/lt.24677","article-title":"Immunosuppression in pediatric liver transplant recipients: unique aspects.","volume":"23","author":"Miloh","year":"2017","journal-title":"Liver Transpl."},{"key":"B7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/CNQ.0000000000000117","article-title":"Immunosuppression in solid-organ transplantation: essentials and practical tips.","volume":"39","author":"Jasiak","year":"2016","journal-title":"Crit Care Nurs Q."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/164_2019_331","article-title":"Immunosuppressants in organ transplantation.","volume":"261","author":"T\u00f6nshoff","year":"2020","journal-title":"Handb Exp Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity-what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis."},{"key":"B10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2007.00136.x","article-title":"Mycophenolate mofetil.","volume":"20","author":"Zwerner","year":"2007","journal-title":"Dermatol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol."},{"journal-title":"Niemann-Pick Disease.","year":"2022","author":"Bajwa","key":"B13"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21230","article-title":"Niemann-pick type B: a rare cause of interstitial lung disease.","volume":"14","author":"Sousa Martins","year":"2022","journal-title":"Cureus."},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1389200219666181031113505","article-title":"Metabolic pathway of Cyclosporine A and its correlation with nephrotoxicity.","volume":"20","author":"Wu","year":"2019","journal-title":"Curr Drug Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1016\/j.transproceed.2011.09.064","article-title":"Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.","volume":"43","author":"Riveiro-Barciela","year":"2011","journal-title":"Transplant Proc."},{"key":"B17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1399-0012.1995.tb00342.x","article-title":"Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.","volume":"9","author":"O\u2019Gorman","year":"1995","journal-title":"Clin Transplant."},{"key":"B18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","article-title":"Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.","volume":"16","author":"Broen","year":"2020","journal-title":"Nat Rev Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.972978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:10:54Z","timestamp":1728666654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.972978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":18,"alternative-id":["10.3389\/fmed.2022.972978"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.972978","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"972978"}}